Hepatic induction of HO-1 reduces not only hepatic steatosis but also decreases inflammatory factors such as suppressor of cytokine signaling-1, interleukin-6, and tumor necrosis factor-alpha (Figure 1). This evidence concerns the gene HMOX1 and fatty liver disease.